Health & Wellness CHMP Issues Positive Opinion for Imuldosa®, Accord’s Stelara® Biosimilar Oct 19, 2024 Accord announces CHMP's positive opinion for Imuldosa®, a biosimilar of Stelara®, indicated for various immunology conditions.